The global chondroitin sulfate market growth is driven by the rising awareness towards joint health and the introduction of novel chondroitin sulfate combination products.

Increasing demand for nutraceutical products is expected to drive growth in the forecast period.

Chondroitin sulfate is used in dietary supplements and food products as thickeners, additives, forming agents, preservatives, in health food, and in animal feed.  It is extensively used due to its ability to treat pets suffering from joint pain and arthritis, including diseases such as chronic pain and aches from osteoarthritis, elbow dysplasia, and hip dysplasia. Food grade and animal feed grade applications are presumed to drive the market growth in the forecast period.

It is also used to improve digestive function, enhance liver function, lower blood sugar, and inhibit tumor metastasis. The growing popularity of its use in the treatment of osteoarthritis and several other treatments is expected to benefit the overall market growth.

Growth in the pharmaceutical and personal care industry is expected to drive the market growth

Growth in the pharmaceutical and personal care industry owing to changing lifestyles and increasing healthcare expenditure may foster the product demand. The rising application of chondroitin sulfate in medicines is to cure joint pain and inflammation, which may drive the overall market growth. Growth in the personal care industry owing to increasing personal care expenditure may drive the product market size. The product is used in skin and hair repair creams and lotions owing to its ability to moisturize, heal and soothe skin. Chondroitin sulfate is also used in skincare products owing to its benefits such as anti-inflammatory properties and skin’s intercellular matrix reinforcement ability, thereby stimulating the product demand.

Regulatory obstruction is likely to hinder the market growth

However, religious & cultural impediments on the usage of chondroitin sulfate (Middle Eastern countries) are a few of the factors restricting the growth of the global chondroitin sulfate market.